177Lu-PSMA-617androgen receptor pathway inhibitorspoly-ADP ribose polymerase (PARP) inhibitorsprostate cancermHSPCmCRPCchemotherapyhigh risk biochemical recurrence
…chemotherapy, poly-ADP ribose polymerase (PARP) inhibitors, and 177Lu-PSMA-617 in this disease space. Finally, as patients with prostate cance…